GRIFOLS reported EUR680.58M in Ordinary Share Capital for its fiscal quarter ending in June of 2026.





Ordinary Share Capital Change Date
Alcon AG USD 487.4M 0 Mar/2026
Almirall EUR 214.79M 0 Dec/2025
Amadeus IT EUR 419.99M 2.37M Jun/2026
Amarin USD 20.81M 13K Dec/2025
argenx SE USD 62.54M 2.74M Jun/2026
AstraZeneca USD 1.55B 44K Jun/2026
Bayer EUR 982.42M 0 Mar/2026
Cie Automotive EUR 118.62M 1.1M Dec/2025
Demant DKK 210.9M 5.18M Dec/2025
Ence Energia y Celulosa EUR 242.25M 0 Mar/2026
Essilor EUR 463.19M 144.06K Jun/2026
Ferrovial EUR 730.59M 9.97M Jun/2026
Fresenius EUR 563.24M 0 Dec/2025
Fresenius Medical Care EUR 270.09M 9.2M Mar/2026
Genmab DKK 61.62M 52K Dec/2025
GlaxoSmithKline GBP 4.08B 20.6M Jun/2026
GRIFOLS EUR 680.58M 6K Jun/2026
Hikma Pharmaceutical USD 221.89M 181.89M Dec/2025
Inditex EUR 3.12B 0 Mar/2026
Lakefront Biotherapeutics EUR 65.9M 0 Mar/2026
Merck EUR 434.78M 0 Mar/2026
Novartis USD 1.9B 7.38M Jun/2026
Philips EUR 952.02M 729K Mar/2026
Roche Holding CHF 796.77M 1.15M Jun/2026
Sanofi EUR 1.21B 8.25M Mar/2026
Smith & Nephew USD 875.95M 11.64K Jun/2026
UCB EUR 190.36M 365.15K Dec/2025
Viscofan EUR 45.6M 1.28M Jun/2026